Cross-sectional study reveals high nutritional risk and unmet needs in multiple myeloma patients, indicating critical gaps in care.
Background Multiple myeloma patients experience nutritional vulnerability through disease-related factors, treatment toxicity, and systemic inflammation, yet comprehensive assessment integrating validated nutrition screening with health equity dimensions remains limited. This study characterized nutritional vulnerability prevalence, determinants, and supportive-care access barriers among Chinese multiple myeloma patients. Methods This single-center, cross-sectional observational study conducted at Shanxi Provincial Key Laboratory, Taiyuan, China (January 2020–December 2024) employed comprehensive assessment including Patient-Generated Subjective Global Assessment Short Form (PG-SGA-SF), Edmonton Symptom Assessment System (ESAS), EORTC QLQ-C30/MY20 quality of life questionnaires, anthropometry, handgrip strength, biochemical markers, food insecurity screening and systematic barriers evaluation. Multivariable logistic regression identified independent predictors of composite nutritional vulnerability; principal component analysis explored multidimensional phenotype structure. Results Among 286 patients completing assessment (mean age 59.8 ± 13.0 years; 52.4% male; 49.3% relapsed/refractory), 57.3% (95% CI: 51.6–62.9) had moderate-to-high nutritional risk, including 7.0% with critical vulnerability. Risk increased across treatment phases (50.7% newly diagnosed, 44.7% remission, 63.7% relapsed, 74.0% refractory; p-trend = 0.002), and composite nutritional vulnerability affected 61.2%. High symptom burden (ESAS ≥40) was dominant independent correlate (adjusted OR = 5.03, 95% CI: 3.08–10.05; p < 0.001), whereas disease stage and treatment intensity were not independently associated. Despite risk, 61.6% of affected patients had unmet nutritional support needs. Oral nutritional supplement use occurred in 45.1% overall, with only modest variation by risk status (42.6–50.0%; p = 0.035). Food insecurity affected 48.3% of patients, demonstrated a strong income gradient ( p < 0.001), and remained independently associated with vulnerability (adjusted OR = 2.12, 95% CI: 1.39–3.24). Nutritional vulnerability was associated with large quality-of-life deficits in global health, physical, and role functioning (adjusted mean differences 35.9–40.5 points; all p < 0.001). Conclusion Nutritional vulnerability in multiple myeloma is highly prevalent, symptom-driven, and inadequately addressed despite devastating quality of life impact, with food insecurity and systemic access barriers compounding clinical risk among socioeconomically vulnerable populations.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: